1J5
SGXHyphens Pharma International Ltd
Health CareSingapore
Financial Summary
| Metric | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Revenue | $177.4M | $195.4M | $170.6M | $162.3M |
| EBITDA | - | - | - | - |
| Net Profit | $5.8M | $10.2M | $8.6M | $11.4M |
| EPS | - | - | - | - |
| DPS | - | - | - | - |
Balance Sheet
Total Assets$79.5M
Total Liabilities-
Equity$70.1M
Net Debt$-17.4M
Cash$26.8M
NTA/Share-
FY25
Price Chart
Insufficient price data
Key Metrics
P/E Ratio15.75
P/B Ratio1.39
EV/EBITDA4.83
Dividend Yield4.8%
ROE8.3%
ROA6.9%
Net Margin3.3%
Debt/Equity0.13
Net Debt/EBITDA-1.02
FCF Yield-
Governance Score
-
SGX Code of Corporate Governance
StocksSG provides data for informational purposes only. This is not financial advice. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.